BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23963825)

  • 41. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
    Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G
    Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
    Huang H; Huang PC
    Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
    Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
    Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.
    Novello C; Pazzaglia L; Cingolani C; Conti A; Quattrini I; Manara MC; Tognon M; Picci P; Benassi MS
    Int J Oncol; 2013 Feb; 42(2):667-75. PubMed ID: 23229283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
    Wang M; Yang W; Li M; Li Y
    Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.
    Shinden Y; Akiyoshi S; Ueo H; Nambara S; Saito T; Komatsu H; Ueda M; Hirata H; Sakimura S; Uchi R; Takano Y; Iguchi T; Eguchi H; Sugimachi K; Kijima Y; Ueo H; Natsugoe S; Mimori K
    Anticancer Res; 2015 Jan; 35(1):123-7. PubMed ID: 25550542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection.
    Zhang WY; Li GD; Liu WP; Ouyang Q; Ren XC; Li FY; Xu H
    Chin Med J (Engl); 2005 Sep; 118(18):1542-8. PubMed ID: 16232331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells.
    Moriai S; Takahara M; Ogino T; Nagato T; Kishibe K; Ishii H; Katayama A; Shimizu N; Harabuchi Y
    Clin Cancer Res; 2009 Nov; 15(22):6771-9. PubMed ID: 19887486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication.
    Quan R; Wei L; Zhu S; Wang J; Cao Y; Xue C; Yan X; Liu J
    Sci Rep; 2016 Jun; 6():27917. PubMed ID: 27302568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
    Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
    Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
    Xu Z; Zeng X; Tian D; Xu H; Cai Q; Wang J; Chen Q
    Biochem Biophys Res Commun; 2014 Oct; 453(4):833-8. PubMed ID: 25450356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-375 inhibits cell growth and correlates with clinical outcomes in tongue squamous cell carcinoma.
    Jia L; Huang Y; Zheng Y; Lyu M; Zhang C; Meng Z; Gan Y; Yu G
    Oncol Rep; 2015 Apr; 33(4):2061-71. PubMed ID: 25633534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
    Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
    Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.
    Li Y; Zhang B; Li W; Wang L; Yan Z; Li H; Yao Y; Yao R; Xu K; Li Z
    Leuk Res; 2016 Oct; 49():73-9. PubMed ID: 27596960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
    Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
    Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.